adamantane has been researched along with Coronary Artery Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatt, DL; Braunwald, E; Cavallari, I; Im, K; Leiter, LA; McGuire, DK; Mosenzon, O; Raz, I; Scirica, BM; Steg, PG | 1 |
| Eskenazi, D; Fisman, EZ; Goldenberg, I; Goldkorn, R; Klempfner, R; Leor, J; Naftali-Shani, N; Tenenbaum, A; Younis, A | 1 |
| Aass, HCD; Åkra, S; Arnesen, H; Byrkjeland, R; Njerve, IU; Seljeflot, I; Solheim, S; Weiss, TW; Øvstebø, R | 1 |
| Bergmark, BA; Bhatt, DL; Bohula, E; Braunwald, E; Cahn, A; Gurmu, Y; Morrow, DA; Mosenzon, O; Raz, I; Scirica, BM; Steg, PG | 1 |
| Scheen, AJ | 1 |
| Favarato, D; Garzillo, CL; Girardi, P; Hueb, W; Kalil Filho, R; Lima, EG; Rahmi, RM; Ramires, JA; Rezende, PC; Strunz, CM; Takiuti, M; Uchida, AH | 1 |
1 review(s) available for adamantane and Coronary Artery Disease
| Article | Year |
|---|---|
Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: from risk factors to clinical outcomes.
Topics: Adamantane; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular System; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Lipids; Nitriles; Pyrazines; Pyrrolidines; Risk Factors; Sitagliptin Phosphate; Triazoles; Vildagliptin | 2013 |
3 trial(s) available for adamantane and Coronary Artery Disease
| Article | Year |
|---|---|
The addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study.
Topics: Adamantane; Aged; Biomarkers; C-Reactive Protein; Cardiac Rehabilitation; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation Mediators; Interleukin-1beta; Israel; Male; Metformin; Middle Aged; Nitriles; Prospective Studies; Pyrrolidines; Time Factors; Treatment Outcome; Up-Regulation; Vildagliptin | 2017 |
A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease.
Topics: Adamantane; Aged; Anti-Inflammatory Agents; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Interleukin-10; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Metformin; Middle Aged | 2017 |
Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease.
Topics: Adamantane; Aged; Body Mass Index; Calibration; Cohort Studies; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diet; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Endpoint Determination; Female; Humans; Life Style; Male; Middle Aged; Myocardial Infarction; Registries; Risk Assessment; Risk Factors; Secondary Prevention; Stroke | 2018 |
2 other study(ies) available for adamantane and Coronary Artery Disease
| Article | Year |
|---|---|
Causes and Risk Factors for Death in Diabetes: A Competing-Risk Analysis From the SAVOR-TIMI 53 Trial.
Topics: Adamantane; Aged; Biomarkers; Cause of Death; Coronary Artery Disease; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Female; Heart Disease Risk Factors; Humans; Male; Mortality; Risk Assessment | 2021 |
Effect of hypoglycemic agents on ischemic preconditioning in patients with type 2 diabetes and symptomatic coronary artery disease.
Topics: Adamantane; Aged; Carbamates; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Ischemic Preconditioning; Male; Middle Aged; Nitriles; Piperidines; Prospective Studies; Pyrrolidines; Vildagliptin | 2013 |